Phase II Proof of Concept Trial of Civamide Patch in the Treatment of Postherpetic Neuraligia.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Feb 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zucapsaicin (Primary)
Indications Neuropathic pain; Postherpetic neuralgia
Focus Proof of concept; Therapeutic Use
Sponsors Winston Laboratories

Most Recent Events

17 Nov 2009 According to a Winstone Laoratories media release, based on positive results obtained from this trial, two pivotal phase III trials (see profile 700051244 and 700051245) are planned to be initiated.
17 Nov 2009 Positive, top-line results announced, according to a Winston Laboratories media release.
16 Oct 2009 Planned number of patients changed from 20 to 22 as reported by ClinicalTrials.gov.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight